| Announce Date | 11/05/2025 |
| EPS Normalized Actual | $0.1086 (Beat by $0.3086) |
| EPS GAAP Actual | $0.1086 (Beat by $0.3086) |
| Revenue Actual | $0.015774B |
| Revenue Surprise | Beat by $15.774M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2026 | 0 | INF | 0 | 0 | 0 |
| Dec 2025 | -0.33 | -0.48 | -0.33 | -0.33 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ1 2025 (Mar 2025) | -0.07 | -0.07 | 0.015774B | 23.7% | 15.77M |
| FQ1 2024 (Mar 2024) | -0.0872 | -0.0872 | 0.012035B | 100% | 12.04M |
| FQ2 2024 (Jun 2024) | -0.11 | -0.11 | 0.012938B | 21.33% | 12.94M |
| FQ3 2024 (Sep 2024) | -0.11 | -0.11 | 0.014943B | 35.27% | 14.94M |
| FQ4 2024 (Dec 2024) | 0.0938 | 0.0938 | 0.022819B | 38.82% | 22.82M |
| FQ2 2023 (Jun 2023) | -0.21 | -0.21 | 0.010178B | 100% | 10.18M |
| FQ3 2023 (Sep 2023) | -0.16 | -0.16 | 0.009673B | 100% | 9.67M |
| FQ4 2023 (Dec 2023) | -0.0938 | -0.0938 | 0.01396B | 100% | 13.96M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2029 (Sep 2029) | -0.16 | -- | -0.16 | -0.16 | 1 |
| FQ2 2029 (Jun 2029) | -0.16 | -- | -0.16 | -0.16 | 1 |
| FQ1 2029 (Mar 2029) | -0.18 | -- | -0.18 | -0.18 | 1 |
| FQ4 2028 (Dec 2028) | -0.19 | -- | -0.19 | -0.19 | 1 |
| FQ3 2028 (Sep 2028) | -0.2 | -- | -0.2 | -0.2 | 1 |
| FQ2 2028 (Jun 2028) | -0.38 | -- | -0.38 | -0.38 | 1 |
| FQ1 2028 (Mar 2028) | -0.37 | -- | -0.37 | -0.37 | 1 |
| FQ4 2027 (Dec 2027) | -0.35 | -- | -0.35 | -0.35 | 1 |
| FQ3 2027 (Sep 2027) | -0.36 | -- | -0.36 | -0.36 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2029 (Sep 2029) | 0.08B | -- | 0.08B | 0.08B | 1 |
| FQ2 2029 (Jun 2029) | 0.08B | -- | 0.08B | 0.08B | 1 |
| FQ1 2029 (Mar 2029) | 0.07B | -- | 0.07B | 0.07B | 1 |
| FQ4 2028 (Dec 2028) | 0.07B | -- | 0.07B | 0.07B | 1 |
| FQ3 2028 (Sep 2028) | 0.06B | -- | 0.06B | 0.06B | 1 |
| FQ2 2028 (Jun 2028) | 0.05B | -- | 0.05B | 0.05B | 1 |
| FQ1 2028 (Mar 2028) | 0.05B | -- | 0.05B | 0.05B | 1 |
| FQ4 2027 (Dec 2027) | 0.04B | -- | 0.04B | 0.04B | 1 |
| FQ3 2027 (Sep 2027) | 0.04B | -- | 0.04B | 0.04B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
7
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ1 2025 (Mar 2025) | -0.07 | -0.07 | 100% | |
| FQ1 2024 (Mar 2024) | -0.0872 | -0.0872 | 100% | |
| FQ2 2024 (Jun 2024) | -0.11 | -0.11 | 100% | |
| FQ3 2024 (Sep 2024) | -0.11 | -0.11 | 100% | |
| FQ4 2024 (Dec 2024) | 0.0938 | 0.0938 | 100% | |
| FQ2 2023 (Jun 2023) | -0.21 | -0.21 | 100% | |
| FQ3 2023 (Sep 2023) | -0.16 | -0.16 | 100% | |
| FQ4 2023 (Dec 2023) | -0.0938 | -0.0938 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ1 2025 (Mar 2025) | $0B | $0.02B | $15.77M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.01B | $12.04M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.01B | $12.94M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.01B | $14.94M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.02B | $22.82M | 100% |
| FQ2 2023 (Jun 2023) | $0B | $0.01B | $10.18M | 100% |
| FQ3 2023 (Sep 2023) | $0B | $0.01B | $9.67M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.01B | $13.96M | 100% |